Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MADCO-PC: AD Markers and Cognition After Anesthesia
NCT01993836Phase 4Completed
- Sponsor
- Duke University
- Start
- Nov 2013
- Primary completion
- Jan 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of propofol injection (veterinary), isoflurane in Alzheimer's disease (AD), postoperative delirium (POD), Post-operative cognitive dysfunction (POCD), sponsored by Duke University. Started Nov 2013; status: completed.
02
Drugs
propofol injection (veterinary)isoflurane
03
Conditions
Alzheimer's disease (AD)postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT01993836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993836.